Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts

PURPOSE: Three new therapies have been approved recently for the adjuvant treatment of stage III melanoma, substantially reducing the risk of tumor recurrences. This study evaluates 3 independent data sets to clarify the survival probabilities of patients with stage III melanoma. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbe, Claus, Keim, Ulrike, Suciu, Stefan, Amaral, Teresa, Eigentler, Thomas K., Gesierich, Anja, Hauschild, Axel, Heinzerling, Lucie, Kiecker, Felix, Schadendorf, Dirk, Stadler, Rudolf, Sunderkötter, Cord, Tüting, Thomas, Utikal, Jochen, Wollina, Uwe, Zouboulis, Christos C., Keilholz, Ulrich, Testori, Alessandro, Martus, Peter, Leiter, Ulrike, Eggermont, Alexander M. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392743/
https://www.ncbi.nlm.nih.gov/pubmed/32530760
http://dx.doi.org/10.1200/JCO.19.03034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392743/
https://www.ncbi.nlm.nih.gov/pubmed/32530760
http://dx.doi.org/10.1200/JCO.19.03034

Ejemplares similares